Porreca F - Search Results

1

Kappa opioid receptor agonists produce sexually dimorphic and prolactin-dependent hyperalgesic priming.

Kopruszinski CM, Watanabe M, Martinez AL, de Souza LHM, Dodick DW, Moutal A, Neugebauer V, Porreca F, Navratilova E. Kopruszinski CM, et al. Among authors: porreca f. Pain. 2023 Jun 1;164(6):e263-e273. doi: 10.1097/j.pain.0000000000002835. Epub 2022 Nov 29. Pain. 2023. PMID: 36625833 Free PMC article.

2

Editorial: Chronic orofacial pain.

Kopruszinski CM, Porreca F, Chichorro JG. Kopruszinski CM, et al. Among authors: porreca f. Front Pain Res (Lausanne). 2023 Jan 4;3:1086256. doi: 10.3389/fpain.2022.1086256. eCollection 2022. Front Pain Res (Lausanne). 2023. PMID: 36688086 Free PMC article. No abstract available.

3

Prolactin and pain of endometriosis.

Lee GJ, Porreca F, Navratilova E. Lee GJ, et al. Among authors: porreca f. Pharmacol Ther. 2023 Jul;247:108435. doi: 10.1016/j.pharmthera.2023.108435. Epub 2023 May 9. Pharmacol Ther. 2023. PMID: 37169264 Review.

4

Considering Patient Sex in Prescribing CGRP Receptor Antagonists for Short-Term Treatment of Migraine.

Porreca F, Dodick DW. Porreca F, et al. JAMA Neurol. 2023 Sep 1;80(9):885-886. doi: 10.1001/jamaneurol.2023.2335. JAMA Neurol. 2023. PMID: 37486684

5

Discovery and characterization of prolactin neutralizing monoclonal antibodies for the treatment of female-prevalent pain disorders.

Maciuba S, Bowden GD, Stratton HJ, Wisniewski K, Schteingart CD, Almagro JC, Valadon P, Lowitz J, Glaser SM, Lee G, Dolatyari M, Navratilova E, Porreca F, Rivière PJM. Maciuba S, et al. Among authors: porreca f. MAbs. 2023 Jan-Dec;15(1):2254676. doi: 10.1080/19420862.2023.2254676. MAbs. 2023. PMID: 37698877 Free PMC article.

6

Identification of brain areas in mice with peak neural activity across the acute and persistent phases of post-traumatic headache.

Rudolph M, Kopruszinski C, Wu C, Navratilova E, Schwedt TJ, Dodick DW, Porreca F, Anderson T. Rudolph M, et al. Among authors: porreca f. Cephalalgia. 2023 Nov;43(11):3331024231217469. doi: 10.1177/03331024231217469. Cephalalgia. 2023. PMID: 38016977 Free PMC article.

7

Potential treatment targets for migraine: emerging options and future prospects.

Chiang CC, Porreca F, Robertson CE, Dodick DW. Chiang CC, et al. Among authors: porreca f. Lancet Neurol. 2024 Mar;23(3):313-324. doi: 10.1016/S1474-4422(24)00003-6. Lancet Neurol. 2024. PMID: 38365382 Review.

8

Patient Sex in Prescribing CGRP Receptor Antagonists for Migraine-Reply.

Porreca F, Dodick DW. Porreca F, et al. JAMA Neurol. 2024 Feb 26. doi: 10.1001/jamaneurol.2023.5838. Online ahead of print. JAMA Neurol. 2024. PMID: 38407903 No abstract available.

9

Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex.

Porreca F, Navratilova E, Hirman J, van den Brink AM, Lipton RB, Dodick DW. Porreca F, et al. Cephalalgia. 2024 Mar;44(3):3331024241238153. doi: 10.1177/03331024241238153. Cephalalgia. 2024. PMID: 38477313 Free article. Review.

10

Female-selective mechanisms promoting migraine.

Singh S, Kopruszinski CM, Watanabe M, Dodick DW, Navratilova E, Porreca F. Singh S, et al. Among authors: porreca f. J Headache Pain. 2024 Apr 24;25(1):63. doi: 10.1186/s10194-024-01771-w. J Headache Pain. 2024. PMID: 38658853 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

637 results

Search Page

Filters